HIV-1 and intestinal helminth review update: Updating a Cochrane Review and building the case for treatment and has the time come to test and treat?

Parasite Immunology

Volumn 31, Issue 6, 2009, Pages 283-286

  Alexander, P E ^a,b   De, P ^c  

^a NCE Division ^*  (Canada)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c Societe canadienne du cancer   (Canada)

Author keywords

Acquired immunodeficiency syndrome; Albendazole; Helminth; HIV 1; Immune modulation

Indexed keywords

ALBENDAZOLE; VIRUS RNA;

CD4 LYMPHOCYTE COUNT; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COCHRANE LIBRARY; DISEASE COURSE; HELMINTH; HELMINTHIASIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; PLASMA; PRIORITY JOURNAL; REVIEW; SOIL; VIRUS TRANSMISSION; WORM;

ALBENDAZOLE; ANTIFUNGAL AGENTS; CD4 LYMPHOCYTE COUNT; HELMINTHIASIS; HIV INFECTIONS; HIV-1; HUMANS; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1; VERMES;

EID: 66449100100     PISSN: 01419838     EISSN: 13653024     Source Type: Journal    
DOI: 10.1111/j.1365-3024.2009.01100.x     Document Type: Review

References (19)

1. Venugopal PG, Nutman TB Semnani RT. Activation and regulation of Toll-Like Receptors (TLRs) by helminth parasites. Immunol Res 2008 Epub ahead of print.
2. Borkow G Bentwich Z. HIV and helminth co-infection: is de-worming necessary? Parasite Immunol 2006 28 (11 605 612. (Pubitemid 44581386)
3. van Riet E, Hartgers FC Yazdanbakhsh M. Chronic helminth infections induce immunomodulation: consequences and mechanisms. Immunobiology 2007 212 (6 475 490. Epub 2007 April 20. (Pubitemid 46825248)
4. Borkow G Bentwich Z. Chronic parasite infections cause immune changes that could affect successful vaccination. Trends Parasitol 2008 June 24 (6 243 245. Epub 2008 April 30.
5. Secor WE Sundstrom JB. Below the belt. new insights into potential complications of HIV-1/schistosome coinfections. Curr Opin Infect Dis 2007 20 (5 519 523. (Pubitemid 47359650)
6. Walson JL John-Stewart G. Treatment of helminth co-infection in HIV-1 infected individuals in resource-limited settings. Cochrane Database Syst Rev 2008 January 23 (1 CD006419.
7. Walson JL, Otieno PA, Mbuchi M, et al. Albendazole treatment of HIV-1 and helminth co-infection: a randomized, double-blind, placebo-controlled trial. AIDS 2008 22 (13 1601 1609.
8. Walson JL John-Stewart G. Treatment of helminth co-infection in individuals with HIV-1: a systematic review of the literature. PLoS Negl Trop Dis 2007 1 (3 e102.
9. Rousseau CM, Nduati RW, Richardson BA, et al. Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 2003 187 (5): 741 747. Epub 2003 February 18. (Pubitemid 36286934)
10. Gupta SB, Jacobson LP, Margolick JB, et al. Estimating the benefit of an HIV-1 vaccine that reduces viral load set point. J Infect Dis 2007 195 : 546 550. (Pubitemid 46214397)
11. Urassa W, Bakari M, Sandström E, et al. Rate of decline of absolute number and percentage of CD4 T lymphocytes among HIV-1-infected adults in Dar es Salaam, Tanzania. AIDS 2004 18 (3 433 438. (Pubitemid 38365870)
12. Fleming TR. Surrogate markers in AIDS and cancer trials. Stat Med 1994 13 (13-14 1423 1435 discussion 1437 40. (Pubitemid 24236194)
13. Modjarrad K, Chamot E Vermund SH. Impact of small reductions in plasma HIV RNA levels on the risk of heterosexual transmission and disease progression. AIDS 2008 22 (16 2179 2185.
14. Bentwich Z, Teicher CL Borkow G. The helminth HIV connection: time to act. AIDS 2008 22 (13 1611 1614.
15. World Health Organization (WHO). Scaling up antiretroviral therapy in resource-limited settings: treatment guidelines for a public health approach. 2003 revision. When to start ARV therapy in adults and adolescents. Available at http://www.who.int/3by5/publications/guidelines/en/arv-guidelines.pdf (accessed November 8th 2008).
16. The New Worm Control Strategy. World Health Organization (WHO). Available at http://www.who.int/wormcontrol/statistics/control
17. Meya DB McAdam KP. The TB pandemic: an old problem seeking new solutions. J Intern Med 2007 261 (4 309 329. (Pubitemid 46474764)
18. Hillier SD, Booth M, Muhangi L, et al. Plasmodium falciparum and helminth coinfection in a semi urban population of pregnant women in Uganda. J Infect Dis 2008 198 (6 920 927.
19. Elias D, Mengistu G, Akuffo H Britton S. Are intestinal helminths risk factors for developing active tuberculosis? Trop Med Int Health 2006 11 (4 551 558.